Browse Articles
Discover research articles across all indexed journals
Chirality‐Induced Twisted Supramolecular Assembly Unlocks Ultrahigh Energy Density at Elevated Temperatures
ABSTRACT To meet the demands of high‐power‐density electronics, high‐temperature‐resistant polymer dielectrics are essential for ensuring reliable operation. Although doping with molecular semiconductors effectively improves the high‐temperature performance of polymer dielectrics, the semiconductors often exist in an isolated, discontinuous distribution. Beyond the inherent issues of poor dispersion and interfacial incompatibility, this morphology may also form conductive pathways under excessive doping, resulting in severe degradation of dielectric properties. Herein, we incorporated chiral molecules e.g., (13bR)‐5,6‐dihydro‐5‐(trans‐4‐propylcyclohexyl)‐4H‐dinaphtho[2,1‐f:1’,2’‐h][1,5]dioxonin (R5011) and its chiral enantiomer (S5011) into polyethersulfone (PES) to construct supramolecular chiral co‐assembly structure. Through π – π stacking interactions, the chiral molecules give rise to an amplified and emergent chiral expression at the macroscopic polymer chain level. The local twisted structure formed by chiral amplification leads to an enlarged torsional angle between the sulfone‐flanking phenyl rings and constructs carrier traps, thereby significantly enhancing the breakdown strength. Ultimately, the co‐assembly PES achieved high energy densities of 8.73 J cm −3 (150°C) with efficiency of 90% and maximum discharge energy density of 10.08 J cm −3 at 150°C. Furthermore, stacked film capacitors based on the PES composite films demonstrated excellent high‐temperature capacitance stability at 150°C. This work demonstrates a novel approach to designing advanced polymer dielectrics through supramolecular interactions.
Real-world effectiveness and safety of amivantamab plus chemotherapy versus chemotherapy alone in EGFR-mutant NSCLC after osimertinib: A propensity score–matched analysis.
284 Background: Amivantamab plus carboplatin–pemetrexed was approved (Sep 2024) for EGFR-mutant advanced NSCLC post-osimertinib, based on MARIPOSA-2 PFS data (HR 0.48). OS has not reached significance in trial interim analyses, and real-world data remain limited. We compared outcomes of amivantamab-chemotherapy (ami-chemo) versus chemotherapy alone (chemo) post-osimertinib using a federated electronic health record network. Methods: Using the TriNetX Global Collaborative Network (168 healthcare organizations), we identified adults with EGFR-mutant NSCLC (ICD-10 C34.x) and prior osimertinib who received ami-chemo (index: amivantamab with platinum within 30 days) or chemo alone (index: platinum, excluding amivantamab within 30 days). 1:1 propensity score matching balanced cohorts on age, sex, race, Charlson comorbidities, metastatic sites (brain, bone, liver), and labs (albumin, hemoglobin, creatinine, LDH). OS and safety were assessed via risk analysis and Kaplan–Meier with log-rank testing. Results: After matching, 151 pairs were analyzed (median follow-up: ami-chemo 201 vs chemo 365 days). Key outcomes are in the Table. Conclusions: Ami-chemo was associated with significantly lower mortality (30.0% vs 49.0%; p = 0.001) versus chemo alone, though KM-OS was non-significant, likely reflecting asymmetric follow-up. Ami-chemo showed significantly higher VTE and neutropenia, consistent with MARIPOSA-2 trial data. These findings provide early real-world evidence supporting ami-chemo effectiveness post-osimertinib while confirming the need for proactive toxicity management. Outcome Ami-Chemo (%) Chemo (%) P HR (95% CI) Log-rank P Mortality 30.0 49.0 0.001 0.88 (0.60–1.30) 0.518 VTE 25.2 14.0 0.032 0.34 (0.18–0.65) 0.001 Neutropenia 25.0 13.3 0.013 0.42 (0.23–0.74) 0.002 Anemia 32.0 26.0 0.326 0.56 (0.34–0.93) 0.024 Thrombocytopenia 19.2 19.7 0.915 0.74 (0.42–1.33) 0.315 Nausea/vomiting 22.1 17.7 0.426 0.66 (0.36–1.23) 0.187 ED visits 18.6 12.5 0.303 0.41 (0.17–1.00) 0.043 Inpatient admits 40.8 40.0 0.936 0.64 (0.33–1.23) 0.178
Constructing Durable High‐Voltage PVDF‐Based Solid‐State Lithium Metal Batteries via an All‐in‐One Design
ABSTRACT Poly(vinylidene fluoride) (PVDF)‐based solid electrolytes represent a compelling frontier for solid‐state lithium metal batteries. Unfortunately, their practical implementation is severely impeded by high Li + migration energy barrier and pronounced interfacial instabilities, arising from α‐phase‐rich conformations and undesired Li + ‐solvation environments. In this study, an ‘all‐in‐one’ regulation strategy enabled by N‐methylimidazolium bis((trifluoromethyl)sulfonyl)imide (MimTFSI) is proposed, which synergistically engineers a β‐phase polymer matrix for shortened pathways and constructs an anion‐rich solvation sheath for lowered energy barriers, ultimately unlocking fast and stable Li + transport coupled with exceptional interfacial compatibility. Consequently, this integrated solid‐state electrolyte demonstrates a high ionic conductivity of 0.84 mS cm − 1 , supports stable cycling of Li symmetric cells for over 4000 h at 0.1 mA cm − 2 , and delivers outstanding cycling performance in Li/LiNi 0.8 Co 0.1 Mn 0.1 O 2 full cells, retaining 93.8% of its initial capacity after 930 cycles at 0.5 C and 95% over 500 cycles at 1 C. Even under expanded voltage windows, it retains 80% after 580 cycles at 4.4 V and 84% after 160 cycles at 4.5 V. Furthermore, the pouch cell is capable of delivering a discharge capacity of 3.26 mAh cm −2 , demonstrating the strong applicability for next‐generation solid‐state lithium metal batteries.
Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situ
Buried Interface‐Driven Synergistic Homogenization of Self‐Assembled Monolayer and Wide‐Bandgap Perovskite for Efficient and Stable Solar Cells
ABSTRACT Wide‐bandgap (WBG) perovskite solar cells (PSCs) have attracted considerable interest due to their diverse photovoltaic applications, particularly as top cells in tandem solar cell configurations. However, the efficiency and stability of these devices are often limited by inhomogeneity in both the hole‐selective self‐assembled monolayer (SAM) and the mixed‐halide WBG perovskite layer. Here, we propose a buried interface‐driven synergistic homogenization strategy to address these challenges. This strategy involves inserting copper fluoride (CuF 2 ) between the FTO substrate and MeO‐2PACz SAM layer, which promotes the formation of a uniform coverage of the MeO‐2PACz layer with suppressed aggregation due to the strong interaction between CuF 2 and MeO‐2PACz. The improved homogeneity of MeO‐2PACz not only facilitates the interfacial hole extraction but also favors the deposition of high‐quality Cs 0.3 MA 0.15 FA 0.55 PbI 2.7 Br 0.3 perovskite. The resultant perovskite films exhibit superior crystallinity, phase homogeneity, and reduced trap density. Collectively, the optimized devices achieve a champion efficiency of 23.33%. Furthermore, after 1500 h of continuous operation at the maximum power point (MPP), the optimized device retains 90% of its initial efficiency, demonstrating excellent operational stability.
Translational advancement of HCB101, a third-generation SIRPα–Fc ligand trap targeting the CD47-SIRPα axis: Integrated phase 1 monotherapy and phase 1b/2a combination development.
TPS89 Background: The CD47–SIRPα axis functions as a central innate immune checkpoint that suppresses macrophage-mediated phagocytosis and enables tumor immune evasion. Clinical development of CD47-targeted agents has been constrained by on-target hematologic toxicity and a limited therapeutic window. HCB101 is a rationally engineered SIRPα–IgG4 Fc fusion protein incorporating AI-guided structural optimization designed to reduce red blood cell binding while preserving macrophage activation and Fc effector function. Published preclinical studies demonstrated high-affinity CD47 engagement, enhanced phagocytosis, macrophage repolarization within the tumor microenvironment, and broad antitumor activity across xenograft models without hematologic toxicity in nonhuman primates, supporting advancement into clinical evaluation and rational combination development. HCB101 has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of gastric cancer. Methods: HCB101-101 (NCT05892718) is an open-label, first-in-human Phase 1 BOIN-guided dose-escalation study evaluating weekly intravenous HCB101 monotherapy (0.08 to 36 mg/kg) in patients with advanced solid tumors or lymphomas. Primary objectives are safety, tolerability, and determination of the recommended Phase 2 dose (RP2D). Secondary objectives include pharmacokinetics, receptor occupancy, and antitumor activity. HCB101-201 (NCT06771622) is a multicenter Phase 1b/2a multicohort study evaluating HCB101 as an innate immune checkpoint backbone in combination with tumor-specific standard-of-care regimens across nine advanced solid tumor types, including gastric cancer, triple-negative breast cancer, colorectal cancer, head and neck squamous cell carcinoma, hepatocellular carcinoma, ovarian cancer, and small cell lung cancer. The Phase 1b portion employs BOIN-guided dose escalation to establish the combination RP2D, followed by tumor-specific expansion cohorts. Primary endpoints include safety and RP2D determination. Secondary endpoints include pharmacokinetics, pharmacodynamics, and antitumor activity per RECIST v1.1. Enrollment in both studies is ongoing. Clinical trial information: NCT05892718 .
π‐Radical Cascades to <i>Peri</i> ‐Fused Triangulene Dimers
ABSTRACT Open‐shell molecular graphene fragments represent versatile synthons of graphene‐based carbon nanostructures because of their ability to undergo multi‐step π‐radical cascades that enable the formation of multiple bonds and rings in a single step. However, the use of graphene‐based π‐radicals in synthesis remains limited due to our incomplete understanding of their reactivity. This limitation primarily arises from the inherent difficulty of controlling reactions involving multiple reactive centers, as is the case with π‐delocalized radicals. To address this challenge and advance research on π‐radical reactivity, we establish reaction control in a system that can formally feature multiple unpaired π‐electrons. Specifically, we examine oxidative peri ‐fusion of the dihydro‐precursor of the prototypic non‐Kekulé hydrocarbon triangulene. By investigating the reactive intermediates that dictate selectivity, we demonstrate that monoradical, rather than diradical, intermediates play a key role. Through the precise placement of steric bulk around the periphery, we modulate reactivity at specific positions, steering selectivity toward doubly or singly peri ‐fused dimeric products. Our study demonstrates that, when controlled, the reactivity of open‐shell molecular graphene fragments can serve as a step‐economic and synthetically valuable tool.
Leaf anatomical plasticity of Robinia pseudoacacia in response to slope-related soil water heterogeneity on granite slopes
Engineering Interfacial Water for Advanced Electrocatalytic CO <sub>2</sub> Reduction: From Molecular Understanding to Materials Design
ABSTRACT Electrocatalytic CO 2 reduction (CO 2 RR) offers a direct pathway for converting CO 2 gas into fuels and value‐added chemicals. However, achieving CO 2 RR with high activity and stability remains a significant challenge. While previous research has predominantly focused on catalyst design, the role of interfacial water has often been overlooked. Interfacial water can act as the primary proton donor, directly influencing the competition between CO 2 RR and the hydrogen evolution reaction. Moreover, the dynamic hydrogen‐bond network of interfacial water can significantly alter the water dissociation barrier, thereby enhancing selectivity toward CO 2 RR products. This review systematically summarizes the fundamental properties of interfacial water in CO 2 RR, classifies the strategies for modulating interfacial water, and discusses the applicability of these strategies and their impact on CO 2 RR performance. Particular emphasis is placed on the effect of interfacial water structural evolution on the CO 2 RR mechanism, as well as the corresponding characterization techniques. This review provides a structured framework for the study of interfacial water in CO 2 RR and offers guidance for the rational design of high‐efficiency catalysts.
Psychosocial distress and health-related quality of life in women undergoing active treatment for breast and gynaecological cancers: A cross-sectional analysis.
330 Background: Despite advances in systemic therapy, psychosocial distress during active cancer treatment remains under-recognized, particularly in resource-constrained settings. Women undergoing treatment for breast and gynaecological malignancies experience multidimensional distress affecting adherence, functioning, and overall quality of life. This study comprehensively evaluated distress domains and health-related quality of life in women receiving active medical oncology treatment. Methods: In this cross-sectional study, 200 women undergoing active treatment were assessed using the National Comprehensive Cancer Network Distress Thermometer (DT), the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), and the EORTC QLQ-BR23 for the breast cancer subgroup. Scores were linearly transformed to a 0–100 scale. Results: Of 200 participants, 59.5% (n = 119) had breast cancer and 40.5% (n = 81) had gynaecological malignancies. Moderate distress was reported by 44% (n = 88) and severe distress by 15% (n = 30). Prominent practical concerns included financial/insurance burden (23%, n = 46) and childcare responsibilities (23.5%, n = 47). Emotional symptoms were common: worry (38%, n = 76), fear (35.5%, n = 71), and depression (30.5%, n = 61). Fatigue (52.5%, n = 105) was the most frequently endorsed physical concern, followed by sleep disturbance (35.5%, n = 71) and pain (32.5%, n = 65). On EORTC QLQ-C30 (n = 200), the mean Global Health Status/QoL score was 55.75, indicating moderate overall quality of life. Functional domains were relatively preserved, particularly cognitive functioning (75.17) and emotional functioning (73.12). Among symptom scales, fatigue (31.67) and pain (27.42) were the highest-scoring domains, consistent with mild-to-moderate symptom burden. In the breast cancer subgroup (n = 119), QLQ-BR23 functional scales demonstrated good body image (75.84) but low sexual functioning (15.97), largely reflecting reduced sexual activity. Sexual enjoyment was high (86.67) among sexually active participants. Future perspective (57.14) suggested moderate impact on outlook. Among symptom scales, distress related to hair loss (39.22) represented a moderate symptom burden. Conclusions: Women undergoing active treatment for breast and gynaecological cancers experience substantial psychosocial distress alongside measurable quality-of-life impairment, particularly related to fatigue, emotional burden, practical stressors, and sexuality. Routine distress screening and structured integration of psycho-oncology services within standard oncology care pathways are warranted to optimize patient-centric outcomes and treatment adherence.
Structure–Selectivity Relationship Study of IDPi Using Fragment and Remote Site Descriptors
ABSTRACT Imidodiphosphorimidate (IDPi) has emerged as a powerful chiral organocatalyst featuring a specially designed cavity constructed by aryl group‐substituted BINOL units. Despite extensive applications of IDPi in asymmetric reactions, the understanding of its structure–selectivity relationship (SSR) remains underdeveloped. In this study, we employed aryl fragment descriptors for the statistical modeling of IDPi‐catalyzed asymmetric reactions, offering a cost‐effective and efficient approach to explore the SSR of IDPi. Specifically, site parameters of remote sp 2 carbon atoms were defined to capture the features of the distal ring of the aryl substituents. The established statistical models of IDPi‐catalyzed cyanosilylation reactions align well with the mechanistic understandings of the crucial role of C‐H···π and cation‐π interactions between the distal ring of IDPi and substrate in stereo‐control. More selective catalysts for the challenging cyanosilylation reaction of 3‐hexanone were successfully identified by using these descriptors to define and screen the chemical space of IDPi catalysts. This work not only enriches our understanding of the SSR of IDPi catalysts but also highlights the potential application of aryl fragment and remote site parameters as universal descriptors for IDPi in statistical modeling.
A semantically enhanced two-stage framework for few-shot named entity recognition
RelB/ILF2–GM-CSF loop to sustain MDSC-mediated prostate cancer immunosuppression.
105 Background: Prostate cancer (PCa) is characterized by an immunologically “cold” tumor microenvironment (TME), with prominent enrichment of myeloid-derived suppressor cells (MDSCs), which compromises effective antitumor immunity and underlies the poor clinical response to immune checkpoint blockade (ICB). Although MDSCs have been extensively implicated in PCa immune evasion, the tumor-intrinsic signaling mechanisms that educate, sustain, and amplify MDSC expansion and immunosuppressive function remain incompletely understood. Methods: Single-cell RNA sequencing and flow cytometry were employed to quantify and characterize MDSCs within the PCa TME. Tumor cell–MDSC co-culture systems combined with flow cytometric analysis were used to interrogate the role of RelB signaling in MDSC expansion and immunosuppressive activity. RNA sequencing, chromatin immunoprecipitation (ChIP), and RT–qPCR assays were performed to define RelB-mediated transcriptional regulation of CSF2 .LC–MS/MS screening combined with immunofluorescence and co-immunoprecipitation assays was used to define the RelB–ILF2 interaction and RelB ubiquitination, while RelB nuclear translocation was assessed under GM-CSF stimulation. Syngeneic PCa mouse models were used to evaluate the impact of the RelB/ILF2–GM-CSF axis on MDSCs, CD8⁺ T cell function, tumor growth, and PD-1 blockade response. Results: We identified a tumor-intrinsic signaling circuit in PCa cells whereby RelB, a key component of the noncanonical NF-κB pathway, drives MDSC expansion through transcriptional activation of CSF2 . RelB binds to a distal NF-κB element within the CSF2 promoter, thereby enhancing GM-CSF expression. Mechanistically, ILF2 interacts with RelB at the Rel homology domain (Arg176), inhibiting RelB ubiquitination and promoting nuclear accumulation. GM-CSF, in turn, reinforces RelB nuclear translocation, establishing a self-sustaining RelB/ILF2–GM-CSF positive feedback loop. This axis activates STAT3 signaling in MDSCs, promoting their expansion and immunosuppressive function. Disruption of the RelB/ILF2 complex abrogated GM-CSF–driven MDSC expansion, restored CD8⁺ T cell–mediated antitumor immunity, and suppressed tumor growth. Notably, pharmacological targeting of RelB using the inhibitory peptide SN52 significantly enhanced tumor sensitivity to PD-1 blockade. Conclusions: Our findings uncover a previously unrecognized RelB/ILF2–GM-CSF feed-forward loop that sustains MDSC-mediated immunosuppression in PCa by enabling RelB-dependent recycling of GM-CSF signaling. Targeting this axis not only disrupts tumor-driven MDSC expansion but also restores effective CD8⁺ T cell immunity and sensitizes PCa to immune checkpoint therapy, highlighting a promising therapeutic strategy for overcoming immune resistance in advanced PCa.
Crystal Facet‐Dependent Metal‐Support Interaction for Stabilizing Cu <sup>δ+</sup> Species Toward Efficient CO <sub>2</sub> Electroreduction
ABSTRACT Cu δ+ species are recognized as optimal active sites for the electrocatalytic CO 2 reduction reaction. While metal‐support interactions (MSIs) modulate the local microenvironment of Cu δ+ , the intrinsic contribution of support crystallographic facets to these interactions remains obscured by interfering oxygen vacancies. In this work, we present a definitive study decoupling the facet effect from vacancy‐related variables by utilizing CeO 2 supports with comparable oxygen vacancy concentrations. Our findings reveal that Cu single atoms supported on various CeO 2 facets follow a pronounced facet‐dependent stability order of Cu/CeO 2 ‐(110) > Cu/CeO 2 ‐(100) > Cu/CeO 2 ‐(111), yet exhibit facet‐independent methane Faraday efficiency (∼80% at −200 mA/cm 2 ). Mechanistic studies unravel this dichotomy, revealing that identical Cu coordination environments drive the uniform initial activity, whereas distinct surface electronic structures dictate long‐term stability by modulating facet‐dependent MSIs. Specifically, the (110) facet exhibits the strongest MSI, acting as a robust “electron buffer” that securely anchors high‐valent Cu δ+ species and effectively retards their irreversible reductive agglomeration into clusters. By establishing an unambiguous structure–performance relationship under single‐variable conditions, this study provides a rational geometric descriptor for designing long‐lasting CO 2 conversion catalysts.
Measuring agritourism sustainability with coupling coordination: a spatio-temporal study of agriculture-culture-tourism interactions in Chinese underdeveloped regions
Abstract The limited capacity for integration and innovation in rural industries continues to undermine the sustainability of underdeveloped regions. Scientifically assessing the coupled and coordinated development of multi-sector systems has therefore become essential to advancing rural resilience and sustainable transformation. This study introduces the Agriculture-Culture-Tourism Integration System (ACTIS) and captures the dynamic interactions among agriculture, cultural resources, and tourism. Drawing on panel data from representative underdeveloped rural areas during the period 2011–2023, it applies system coupling theory in combination with methods such as entropy-weighted TOPSIS, the coupling coordination model, the standard deviation ellipse, the Theil index, and the geographical detector to construct a comprehensive indicator system for evaluating ACTIS development, spatiotemporal evolution, and driving factors. The results reveal marked spatial and temporal heterogeneity, with uneven sectoral patterns and evolving regional disparities. Coupling coordination shows distinct phases of development and is shaped primarily by internal differences rather than interregional gaps, while infrastructure, geographical indications, human capital, and technological innovation emerge as key drivers. By examining the dynamics and driving mechanisms of ACTIS, this study extends system coupling theory to multi-sector rural contexts. The findings offer important theoretical insights and practical references for promoting industrial transformation, policy innovation, and sustainable development in underdeveloped regions globally.
Systemic epigenetic dysregulation as a driver of ageing and a therapeutic target
Early results from a phase 1/2 clinical study of a urine-based multi-cancer early detection (MCED) assay for prostate, bladder, and kidney cancers.
181 Background: Current diagnostic pathways for kidney, bladder and prostate cancers rely on invasive procedures and imaging. Non-invasive MCED requires robust analyte recovery and accurate tumour signal detection. Urine is an attractive alternative to blood, particularly for genitourinary malignancies. This Phase 1/2 study evaluates feasibility and analytical performance of urine-based circulating tumour DNA (ctDNA) and circulating tumour RNA (ctRNA) versus plasma in early-stage prostate, bladder and kidney cancers, validated against healthy and benign controls. Methods: Patients with biopsy-proven localised prostate, bladder and kidney cancer, plus healthy and benign controls, provided paired urine and blood samples. DNA and RNA were extracted from urine and plasma, quantified, and analysed using amplicon-based targeted next-generation sequencing to detect cancer-associated genomic alterations and transcripts. Sensitivity of urine versus plasma ctDNA was analysed by cancer type. Incremental value of urine ctDNA/ctRNA, particularly for prostate cancer, was assessed. Healthy controls were used for test calibration. A preplanned interim analysis was scheduled upon recruitment of the first 30 participants (n=30). Results: All urine samples (15 control, 15 prostate cancer, 14 bladder cancer, 9 kidney cancer) yielded adequate DNA, with highest concentration from bladder cancer cases. One case was excluded from analysis due to poor on-target reads, possibly from undiagnosed concomitant Serratia urinary tract infection. No cancer-associated alterations were detected in controls, confirming strong assay calibration and specificity. Urine ctDNA markedly outperformed plasma ctDNA for bladder cancer detection, identifying cancer-associated alterations in 92.3% of cases compared with 15.4% in blood. Significantly, 7/10 (70%) of bladder cancer cases detected by urine ctDNA alone belonged to EAU high risk groups including 2 cases of muscle-invasive (pT2) disease, yet urine cytology was only positive in 3/10 (30%). In prostate cancer, detection significantly improved from 6.7% with urine ctDNA alone to 40.0% with combined ctDNA/ctRNA analysis, largely driven by prostate-specific transcripts such as TMPRSS2-ERG fusions. Urine ctRNA was detected in 6/9 (66.7%) of ISUP grade group ≥3 cases. Among those detected by urinary ctRNA alone, 80% (4/5) were ISUP grade group ≥3. Urine also demonstrated improved detection over blood for kidney cancer, although overall sensitivity remained modest (14.3%). Conclusions: Urine is a feasible, analytically robust biospecimen for MCED. Urine ctDNA outperforms plasma for bladder cancer detection, while urine ctRNA enhances prostate cancer detection. Absence of false positives in controls supports good calibration and further evaluation of this urine-based assay.
Toward Practical Design of High‐Entropy Catalysts for Chlorine Evolution Reaction via Pareto‐Guided Multi‐Objective Bayesian Optimization Enabled by a Robotic AI‐Chemist
ABSTRACT The electrocatalytic chlorine evolution reaction (CER) is essential to modern chlor‐alkali industry, yet conventional RuO 2 catalysts suffer from parasitic oxygen evolution. High‐entropy ruthenium oxides (Ru‐HEO) are promising alternatives, but their practical design is hindered by complex composition‐structure‐performance relationship. Herein, we construct a Pareto‐guided multi‐objective Bayesian optimization framework to enable autonomous high‐throughput exploration of quinary Ru‐HEO system. Through this trade‐off strategy, we identify compositions that efficiently balance mass activity, Cl 2 selectivity and material cost. The leading Ru‐HEO catalyst with only 8.4 at% Ru achieves a remarkable activity of 5083 A g −1 Ru at 1.50 V versus RHE and maintains excellent 100‐h stability, outperforming commercial RuO 2 and the state‐of‐the‐art catalysts reported. Integrated into a photovoltaic‐electrochemical (PV‐EC) prototype device and tested under simulated diurnal illumination, it sustains >95% selectivity, a maximum solar‐to‐chemical (STC) efficiency of 14.6% and projected Cl 2 production costs as low as $0.177 per kg. Our work establishes a closed‐loop, AI‐accelerated research paradigm that integrates multi‐objective optimization with robotic experimentation, offering a generalizable and expedited pathway toward high‐performance electrocatalysts for sustainable chemicals manufacturing.
A transformer and large-kernel convolution-based detection model for Red Turpentine Beetle infestation in pine trees
Abstract Infestation by the Red Turpentine Beetle is one of the key factors threatening the ecological stability of pine forests, while traditional manual inspection methods are inefficient and easily influenced by subjective factors. UAV-based detection methods can significantly improve monitoring efficiency; however, small target scales, blurred details, and complex backgrounds in UAV imagery pose great challenges to detection algorithms. To address these issues, This paper proposes TLK-YOLO, a UAV-based method for detecting pine trees infested by the Red Turpentine Beetle, which integrates a Transformer mechanism with a large-kernel selection strategy. A Local Window Cross-Attention (LWCA) upsampling module is introduced to enhance small-object detail modeling by fusing high- and low-resolution information within local windows. A Dynamic Combined Large Selective Kernel (DCLSK) module adaptively adjusts the receptive field to balance global context and local details, improving small-object feature discriminability and robustness. Furthermore, a redesigned network architecture, TLK-NA, mitigates redundancy in shallow-to-deep feature propagation by reversing the information flow from deep to shallow layers, achieving a better trade-off between detection accuracy and computational efficiency. Experimental results demonstrate that TLK-YOLO exhibits remarkable performance in detecting Red Turpentine Beetle infestations from UAV imagery, achieving an mAP50 of 89.3%. Compared with the baseline model, TLK-YOLO attains comprehensive improvements in both detection precision and recall, with precision increases by 4.4%, recall precision by 9.6%, while mAP50 and mAP50-95 improve by 7.9% and 8.3%, respectively, while maintaining relatively low computational overhead. This network provides an efficient and reliable technical foundation for UAV-based forestry pest and disease monitoring.
Diamond Formation at Superlubric Sliding Interface
ABSTRACT Until now, all carbons (solids, liquids, and gases) prefer to graphitize at moving mechanical interfaces. The reverse evolution toward diamond is generally not possible at the interfaces due to high activation and kinetic barriers (Diamond can be grown only at pressures of 5–6 GPa and temperatures of 900°C–1400°C). Here, we report diamond formation at superlubric sliding interfaces (coefficient of friction 0.008), breaking this pattern. This is accomplished by the van der Waals encapsulation of carbonaceous wear debris, when sliding Al 2 O 3 balls against MoS 2 ‐coated amorphous carbon surfaces. Atomistic simulations reveal the encapsulation to reduce potential energy difference (30%) and accelerate structural relaxation dynamics (2.0 times), which triggers a disproportionation transformation that forms diamond. This study observes diamond formation at mechanical moving interfaces, which opens many possibilities for further basic science studies and for this field of mechanical friction.